This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Natural Alternatives International, Inc. Announces New Sustained Release Beta-Alanine Intellectual Property

SAN MARCOS, Calif., Nov. 6, 2012 /PRNewswire/ -- Natural Alternatives International, Inc. ("NAI") (NASDAQ: NAII), a leading formulator, manufacturer and marketer of customized nutritional supplements, announced today that the U.S. Patent and Trademark Office has issued a Notice of Allowance of its patent application directed to sustained release formulations of beta-alanine. This Notice follows the September 14, 2012, issuance of NAI's corresponding sustained release patent in Canada and a similar Notice of Allowance in South Korea.  This new intellectual property becomes part of NAI's growing portfolio covering its CarnoSyn ® beta-alanine and SR CarnoSyn ® product.

Mark A. LeDoux, NAI's CEO and Chairman of the Board, said that "NAI is very excited by the addition of this new intellectual property related to a broad range of sustained release formulations for beta-alanine compositions.  We believe this new patented technology will dramatically expand the use of beta-alanine to a much broader group of consumers.  These new patent rights will not expire until 2028, and further demonstrates our commitment and significant investment in the CarnoSyn ® beta-alanine business."    

Dr. Roger Harris, a named inventor on NAI's new sustained release intellectual property, added, "The use of extended release formulations for beta-alanine is an advancement in supplement intake.  The result is an increase in the beneficial amount of beta-alanine retained in the body while reducing loss through metabolic processes. Additionally, sustained release formulations minimize or reduce parasthesia, a common side effect that can be experienced by those taking beta-alanine as an individual amino acid."  Using sustained release forms of beta-alanine will not only meet the needs of bodybuilders, but also expand into other areas of use by individuals.

Since 2008, over 30 peer-reviewed studies have been published related to beta-alanine supplementation.  Thirteen of these studies were directed to sustained release forms of beta-alanine, eight of which were published in 2012 alone.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,080.54 +56.48 0.31%
S&P 500 2,108.29 +22.78 1.09%
NASDAQ 5,005.3910 +63.9670 1.29%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs